Orca Bio

Orca prepares to make market plunge after phase 3 win

Orca-T offers “good efficacy and low toxicity,” CEO Ivan Dimov said, noting that the combination of features represents the "holy grail" in the space.

Gabrielle Masson Mar 17, 2025 7:00am

Orca Bio co-founders Jeroen Bekaert PhD Ivan Dimov PhD and Nate Fernhoff PhD

Orca Bio, Lyell pen new pact to open up CAR-T for solid tumors

Sep 2, 2020 8:30am

Orca Bio breaches the surface with $192M

Jun 17, 2020 7:00am